| Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice K Nogami, Y Maruyama, F Sakai-Takemura, N Motohashi, A Elhussieny, ... Human molecular genetics 30 (11), 1006-1019, 2021 | 33 | 2021 |
| Prostaglandin EP2 receptor downstream of Notch signaling inhibits differentiation of human skeletal muscle progenitors in differentiation conditions F Sakai-Takemura, K Nogami, A Elhussieny, K Kawabata, Y Maruyama, ... Communications Biology 3 (1), 182, 2020 | 12 | 2020 |
| Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR) A Elhussieny, K Nogami, F Sakai-Takemura, Y Maruyama, N Takemura, ... Stem Cell Research & Therapy 12, 1-16, 2021 | 6 | 2021 |
| Mesenchymal stem cells for regenerative medicine for Duchenne muscular dystrophy A Elhussieny, K Nogami, F Sakai-Takemura, Y Maruyama, ... Muscular Dystrophy-Research Updates and Therapeutic Strategies, 2020 | 4 | 2020 |
| iNOS is not responsible for RyR1 S-nitrosylation in mdx mice with truncated dystrophin K Nogami, Y Maruyama, A Elhussieny, F Sakai-Takemura, J Tanihata, ... BMC Musculoskeletal Disorders 21, 1-10, 2020 | 2 | 2020 |
| Antioxidants restore store‐operated Ca2+ entry in patient‐iPSC‐derived myotubes with tubular aggregate myopathy‐associated Ile484ArgfsX21 STIM1 mutation via upregulation of … F Sakai‐Takemura, F Saito, K Nogami, Y Maruyama, A Elhussieny, ... FASEB BioAdvances 5 (11), 453, 2023 | | 2023 |
| Evaluation of High-Frequency Repetitive Transcranial Magnetic Stimulation Role in improving Motor and Non-motor Manifestations of Parkinson’s Disease in Minia University Hospital MM Abdelkader, WT Soliman, MM Ismail, BHS Soliman, A Elhussieny SVU-International Journal of Medical Sciences 6 (2), 568-578, 2023 | | 2023 |
| iNOS is not responsible for nitrosylation of RyR1 in mdx mice with truncated dystrophin K Nogami, Y Maruyama, A Elhussieny, F Sakai-Takemura, J Tanihata, ... | | 2020 |
| P. 313Improvement of human induced pluripotent stem cells (hiPSCs)-based therapy of Duchenne muscular dystrophy by using mesenchymal stem cells (MSCs) A Elhussieny, K Nogami, F Takemura, Y Maruyama, Y Miyagoe-Suzuki, ... Neuromuscular Disorders 29, S158, 2019 | | 2019 |
